SCHEMBL6823728

SCHEMBL6823728

Cc1ccc(Cl)c2[nH]c3c(c12)CCCC3

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA2A P08913 1/20 0.38
CLCN2 P51788 1/20 0.38
MAPT P10636 7/20 0.38
AR P10275 1/20 0.38
EGFR P00533 3/20 0.37
HTT P42858 2/20 0.36
PTK2B Q14289 1/20 0.36
TP53 P04637 2/20 0.36
LMNA P02545 1/20 0.36
ALDH1A1 P00352 3/20 0.36
ALOX15 P16050 2/20 0.36
MAPK1 P28482 2/20 0.36
HSD17B10 Q99714 2/20 0.36
POLB P06746 2/20 0.36
TAAR1 Q96RJ0 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
DYRK1A Q13627 1/20 0.36
GFER P55789 1/20 0.36
CASP1 P29466 1/20 0.35
CASP7 P55210 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14581535 0.81 TAAR1 (0.55) ADRA2ACLCN2HTTPTK2BTAAR1
SCHEMBL8801548 0.81 TAAR1 (0.44) ADRA2ACLCN2ARHTTPTK2B
Hydrochloric Acid SCHEMBL4792618 0.80 TAAR1 (0.57) ADRA2ACLCN2HTTPTK2BTAAR1
SCHEMBL7464791 0.75 HTR1A (0.38)
SCHEMBL22787314 0.75 AR (0.37) MAPTAREGFRHTTPTK2B
SCHEMBL11742569 0.74 GFER (0.58) ADRA2ACLCN2MAPTEGFRTP53
SCHEMBL18685989 0.70 ALOX15 (0.49) ADRA2ACLCN2MAPTARHTT
SCHEMBL4727564 0.70 TAAR1 (0.62) MAPTLMNAALDH1A1ALOX15MAPK1
SCHEMBL11732994 0.70 GFER (0.57) ADRA2ACLCN2MAPTAREGFR
SCHEMBL12480438 0.70 ADRA2A (0.44) ADRA2AARHTTPTK2BNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040067999-A1 Carbazole derivatives and their use as neuropeptide y5 receptor ligands ASTRAZENECA AB (SE) 2004-04-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040067999-A1 Carbazole derivatives and their use as neuropeptide y5 receptor ligands NPY5R, NPY1R, NPY2R ADRA2A 229/4885CLCN2 3464/4885MAPT 3011/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.